Douglas Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DOUGLAS PHARMS
DOUGLAS PHARMS has one approved drug.
There is one US patent protecting DOUGLAS PHARMS drugs.
There are six patent family members on DOUGLAS PHARMS drugs in six countries.
Drugs and US Patents for Douglas Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Douglas Pharms | VERSACLOZ | clozapine | SUSPENSION;ORAL | 203479-001 | Feb 6, 2013 | RX | Yes | Yes | 8,057,811 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Douglas Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2436213 | ⤷ Start Trial |
| European Patent Office | 1646393 | ⤷ Start Trial |
| Canada | 2532648 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

